TCAF2 is associated with the immune microenvironment, promotes pathogenesis, and impairs prognosis in glioma

Yongshuai Li; Jiaqiong Li; Huaqing Chen; Bo Lü; Fei Lu; Hairong Chen; Hongyi Liu; Chunfa Qian

doi:10.1016/j.gene.2023.147667

ScienceGate Book Chapters

JOURNAL ARTICLE

TCAF2 is associated with the immune microenvironment, promotes pathogenesis, and impairs prognosis in glioma

Yongshuai Li Jiaqiong Li Huaqing Chen Bo Lü Fei Lu Hairong Chen Hongyi Liu Chunfa Qian

Year: 2023 Journal: Gene Vol: 883 Pages: 147667-147667 Publisher: Elsevier BV

DOI: 10.1016/j.gene.2023.147667

Get Full-Text PDF Get Analytical Report

Keywords:

Glioma Biology Immune system Cancer research Tumor microenvironment Malignancy Oncogene Pathogenesis Cancer Downregulation and upregulation Immunology Cell cycle Gene Genetics

Metrics

Cited By

1.88

FWCI (Field Weighted Citation Impact)

Refs

0.84

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Glioma Diagnosis and Treatment

Health Sciences → Medicine → Genetics

Neuroinflammation and Neurodegeneration Mechanisms

Life Sciences → Neuroscience → Neurology

MicroRNA in disease regulation

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

TCAF2 is associated with the immune microenvironment, promotes pathogenesis, and impairs prognosis in glioma

Metrics

Citation History

Topics

Related Documents

ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma

A Novel S100 Family-Based Signature Associated with Prognosis and Immune Microenvironment in Glioma

DLL3 expression and methylation are associated with lower-grade glioma immune microenvironment and prognosis

Immune-related prognosis biomarkers associated with osteosarcoma microenvironment

BZW1 as an oncogene is associated with patient prognosis and the immune microenvironment in glioma